TABLE 2.
d-Alanine requirements for different alr/dadX-deficient strains
Strain | Growth on selective LB mediuma |
|||
---|---|---|---|---|
Km+/d-ala− | Km+/d-ala+ | Km−/d-ala− | Km−/d-ala+ | |
BL21(DE3)ΔalrΔdadX | N | N | N | V |
BL21(DE3)ΔalrΔdadX metJ(R42C)-Kmr | V | V | V | V |
BL21(DE3)ΔalrΔdadXPR | N | N | V | V |
BL21(DE3)ΔalrΔdadXPRmetJ(R42C)-Kmr | V | V | V | V |
BL21(DE3)ΔalrΔdadXPRmetJ-Kmr | N | V | N | V |
BL21(DE3)ΔalrΔdadXΔmetC | N | N | N | V |
BL21(DE3)ΔalrΔdadXPRΔmetC | N | N | N | V |
Km, kanamycin; d-ala, d-alanine; +, in the presence of reagent; −, in the absence of reagent; V, viable; N, not viable.